Home » Authors » Kim Coghill

Kim Coghill

Articles

ARTICLES

Corixa Gets $11.6M Grant From Government For TLR4 Agonists

Jan. 6, 2004

New Jersey Signs Legislation Allowing Stem Cell Research

Jan. 6, 2004

New Jersey Signs Legislation Allowing Stem Cell Research

Jan. 6, 2004

Corixa Gets $11.6M Grant From Government For TLR4 Agonists

Jan. 6, 2004

Medicare Leads 2003; Defining Human Organisms' Still Ahead

Jan. 5, 2004

Medicare Leads 2003; Defining Human Organisms' Still Ahead

Jan. 5, 2004

Nastech, Questcor File NDA For Spray Form Of Nascobal

Dec. 31, 2003

Questcor Pharmaceuticals Inc. and Nastech Pharmaceutical Co. Inc. filed a new drug application requesting approval of Nascobal Nasal Spray for the treatment of vitamin B-12 deficiency. (BioWorld Today)

Nastech, Questcor File NDA For Spray Form Of Nascobal

Dec. 31, 2003

Questcor Pharmaceuticals Inc. and Nastech Pharmaceutical Co. Inc. filed a new drug application requesting approval of Nascobal Nasal Spray for the treatment of vitamin B-12 deficiency. (BioWorld Today)

Pharmion Files NDA On Vidaza For Myelodysplastic Syndromes

Dec. 30, 2003

Pharmion Corp. filed a new drug application seeking approval to market Vidaza, an orphan-designated product, as a treatment for myelodysplastic syndromes. (BioWorld Today)

Pharmion Files NDA On Vidaza For Myelodysplastic Syndromes

Dec. 30, 2003

Pharmion Corp. filed a new drug application seeking approval to market Vidaza, an orphan-designated product, as a treatment for myelodysplastic syndromes. (BioWorld Today)

View All Articles by Kim Coghill

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 6, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...
Serotonin receptor modulators for the treatment of OUD
BioWorld Science
Opioid use disorder (OUD) causes high morbidity and mortality rates, with fentanyl driving unprecedented overdose rates. Researchers from the University of...
KLF15 shows potential as marker, target for cholangiocarcinoma
BioWorld Science
Researchers at the Biodonostia Health Research Institute reported on the role of KLF15 in cholangiocarcinogenesis and its potential as a therapeutic target in...